Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2014

Apr 3, 2014

29875_dirs_2014-04-03_90f40c74-e83a-44d8-8e26-844e7782f540.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2014-04-01

Reporting Person: GOLD STEPHEN J (SVP & CIO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-01 Common Stock (restricted) A 5384 $74.29 Acquired 11345 Direct
2014-04-01 Common Stock (restricted) A 20191 $74.29 Acquired 31536 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-01 Stock Option $74.29 A 33569 Acquired 2021-04-01 Common Stock (33569) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9988.3094 Direct
Common Stock (pep) 9773.8114 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $54.53 2020-04-01 Common Stock (25571) 25571 Direct
Stock Option $47.29 2022-07-09 Common Stock (95160) 95160 Direct

Footnotes

F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019.

F2: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/1/2019.

F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2015.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F5: Option becomes exercisable in three equal annual installments, commencing 07/09/2015.